Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic value and immunological role of CD44 in pan-cancer study

28 Apr 2023

Abstract excerpt

To investigate the correlation between cluster of differentiation-44 (CD44) expression and immunotherapy response and identify its possible predictive value in pan-cancer. Datasets of 33 cancer types from The Cancer Genome Atlas (TCGA) database were applied to investigate the relationship of CD44 expression with prognosis, tumor mutational burden (TMB), and microsatellite instability (MSI), and determine its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37117249
DOI: 10.1038/s41598-023-34154-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic value and immunological role of CD44 in pan-cancer studyPMID 37117249Read ↗

The Prognostic Value and Immunological Role of CD44 in Pan-Cancer StudySemantic proximity Read ↗

CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarkerSemantic proximity Read ↗

CD44 and its implication in neoplastic diseasesSemantic proximity Read ↗

The Cancer Stem Cell Marker CD44 Play Key Roles in Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis in Several Human CancersSemantic proximity Read ↗

Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and MetastasisSemantic proximity Read ↗

A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discoverySemantic proximity Read ↗

CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosisSemantic proximity Read ↗

The epiphany derived from T-cell–inflamed profiles: Pan-cancer characterization of CD8A as a biomarker spanning clinical relevance, cancer prognosis, immunosuppressive environment, and treatment responsesSemantic proximity Read ↗

A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumorsSemantic proximity Read ↗

CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations.Semantic proximity Read ↗

Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancerSemantic proximity Read ↗

Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various CancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.